SURAKSHA DIAGNOSTIC LIMITED — Call Transcript 2026

Jan 29, 2026

==> picture [141 x 6] intentionally omitted <==

==> picture [141 x 11] intentionally omitted <==

==> picture [141 x 12] intentionally omitted <==

==> picture [141 x 11] intentionally omitted <==

==> picture [141 x 6] intentionally omitted <==

==> picture [141 x 6] intentionally omitted <==

Date: 29 January 2026

To The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol : SURAKSHA

Dear Sir / Ma’am,

Reg: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015

Sub: Intimation of schedule of Analyst(s) / Investor(s) meet/ Conference

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conference Call viz. ‘Earnings Call’ for the Analyst(s)/ Investor(s) as below:

==> picture [333 x 16] intentionally omitted <==

----- Start of picture text -----

Date and Time Event Mode Type
----- End of picture text -----

Date and Time Event Mode **Type **	Date and Time Event Mode **Type **	Date and Time Event Mode **Type **	Date and Time Event Mode **Type **
Friday, 06 February 2026 at 2.30 pm (IST)	Discussion on Q3 & 9M FY 2025-26 results	Earnings Call through digital means	Group meet

No unpublished price-sensitive information is proposed to be shared during the aforesaid Earnings Call. Discussions at the event will be based on information that is publicly available. The Investor Presentation on the financial performance of the Company for the quarter and nine months ended 31 December 2025 will be exhibited at the aforesaid meeting and the same shall be duly available on the website of the Company at www.surakshanet.com.

Please note that the schedule of the aforesaid Earnings Call is subject to change. The changes might happen due to exigencies on the part of the Company/ Analyst(s)/ Investor(s).

Further, details as required to be disclosed as per BSE’s Circular No. 20230714-34 dated 14 July 2023, and NSE’s Circular No. NSE/CML/2023/57 dated 14 July 2023 are as under:

Date of occurrence of event/information: Friday, 06 February 2026 Time of occurrence of event/information: 2.30 pm (IST)

Suraksha Diagnostic Limited

==> picture [562 x 6] intentionally omitted <==

CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India

E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone: (033) 6605 9750

==> picture [141 x 6] intentionally omitted <==

==> picture [141 x 11] intentionally omitted <==

==> picture [141 x 12] intentionally omitted <==

==> picture [141 x 11] intentionally omitted <==

==> picture [141 x 6] intentionally omitted <==

==> picture [141 x 6] intentionally omitted <==

The invitation of the aforesaid Earnings Call is enclosed herewith. This may please be informed to all the concerned.

For Suraksha Diagnostic Limited

MAMTA Digitally signed by MAMTA JAIN JAIN Date: 2026.01.29 16:42:44 +05'30'

_____

Mamta Jain

Company Secretary & Compliance Officer

Encl: As above

Suraksha Diagnostic Limited

==> picture [562 x 6] intentionally omitted <==

CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India

E-mail: investors@surakshanet.com I Website: www.surakshanet.com

Phone: (033) 6605 9750

SURAKSHA DIAGNOSTIC LIMITED

==> picture [96 x 63] intentionally omitted <==

==> picture [109 x 29] intentionally omitted <==

Suraksha Diagnostic Limited will host a conference call for analysts and investors to discuss their Q3 & 9M FY26 results

Date and Time: Friday, 06[th] February 2026, at 2:30 PM IST

COMPANY PARTICIPANTS

Dr. Somnath Chatterjee (Chairman and Jt. Managing Director)

Ms. Ritu Mittal (Jt. Managing Director and CEO)

Mr. Ravindra K. S (Group Chief Financial Officer)

Mr. Niren Kaul (Chief Sales Officer)

Mr. Balgopal Jhunjhunwala (Regional Business Head)

CONFERENCE DIAL IN NUMBERS

Universal Dial In :

+91 22 6280 1550 / +91 22 7115 8378

International Toll Free:

Hong Kong : 800964448 UK : 08081011573 Singapore : 8001012045 USA : 18667462133

Please pre-register to avoid wait time:

DIAMOND PASS

Please click here for pre-registration

RSVP

==> picture [101 x 29] intentionally omitted <==

Suraksha Diagnostic Limited

==> picture [84 x 20] intentionally omitted <==

MUFG Intime India Private Limited

Ashish Tendulkar/Pooja Swami

ashish.tendulkar@in.mpms.mufg.com/ pooja.swami@in.mpms.mufg.com

Meeting Request Link – Click Here

1